- Home
- SIEB vs TLSA Comparison
SIEB vs TLSA Comparison
Compare SIEB & TLSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SIEB | TLSA |
|---|---|---|
| Founded | 1886 | 2013 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Investment Bankers/Brokers/Service | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 164.1M | 192.1M |
| IPO Year | N/A | 2000 |
Fundamental Metrics
Financial Performance| Metric | SIEB | TLSA |
|---|---|---|
| Price | $2.54 | $1.43 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 25.2K | ★ 306.6K |
| Earning Date | 03-30-2026 | 05-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.18 | N/A |
| Revenue | ★ $90,289,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $14.21 | ★ N/A |
| Revenue Growth | ★ 8.32 | N/A |
| 52 Week Low | $2.08 | $0.70 |
| 52 Week High | $5.77 | $2.60 |
Technical Indicators
Market Signals| Indicator | SIEB | TLSA |
|---|---|---|
| Relative Strength Index (RSI) | 30.45 | 42.35 |
| Support Level | $2.61 | $1.33 |
| Resistance Level | $2.83 | $1.77 |
| Average True Range (ATR) | 0.18 | 0.11 |
| MACD | -0.01 | -0.01 |
| Stochastic Oscillator | 15.52 | 20.41 |
Price Performance
Historical ComparisonAbout SIEB Siebert Financial Corp.
Siebert Financial Corp is a diversified financial services firm and provides a full range of brokerage and financial advisory services including securities brokerage, investment advisory and insurance offerings, and corporate stock plan administration solutions. The firm mainly provides online and traditional brokerage and related services to retail investors and also acts as an investment advisor for its subsidiary. The company operates in the securities brokerage and asset management industry. It also engages in Insurance services, Robo-advisory technology, and Prime brokerage business through its subsidiaries.
About TLSA Tiziana Life Sciences Ltd.
Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease, and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.